Funding for this research was provided by:
Congressionally Directed Medical Research Programs (MS140019, MS140019P1)
Wellcome Trust (RRZA/057 RG79423)
Addenbrooke's Charitable Trust, Cambridge University Hospitals (RG 97519)
Received: 28 May 2020
Accepted: 30 May 2020
First Online: 9 June 2020
: S.P. is co-founder and CSO at CITC Ltd. and iSTEM Therapeutics, and co-founder and Non-executive Director at Asitia Therapeutics. L.P.J. is Head of Research at iSTEM Therapeutics.